CELL — Phenomex Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- $98.79m
- $67.83m
- $78.60m
Annual cashflow statement for Phenomex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.3 | -18.3 | -41.6 | -71.7 | -98 |
| Depreciation | |||||
| Non-Cash Items | 3.91 | 7.49 | 12.8 | 24.4 | 28 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.69 | -4.57 | -12.2 | -11.4 | 13.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.5 | -10.5 | -35.9 | -53.1 | -47.5 |
| Capital Expenditures | -7.42 | -8.42 | -3.29 | -15.8 | -8.08 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1 | -0.65 | 0 | 0 | -45.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.42 | -9.07 | -3.29 | -15.8 | -54 |
| Financing Cash Flow Items | -0.273 | 0 | -2.65 | -0.3 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 95.6 | 1.02 | 192 | 13.6 | 9.68 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 73.6 | -18.6 | 152 | -55.3 | -91.8 |